How do glucocorticoids such as prednisone work against lymphomas? Read a new study from a multinational team at NCATS and the National Cancer Institute (NCI) to get some answers to that longstanding mystery of cancer treatment: https://lnkd.in/e3qbqhB6
National Center for Advancing Translational Sciences (NCATS)
Research
Bethesda, Maryland 16,694 followers
About us
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, is improving health through smarter science. NCATS conducts and supports research on the science and operation of translation to allow more treatments to get to more patients more quickly. The Center focuses on what is common across diseases and the translational process by studying translation on a system-wide level as a scientific and operational problem. Working in partnership with the public and private sectors, NCATS strives to develop innovations to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline; demonstrate their usefulness; and disseminate the resulting data to the broader scientific community. For more information, visit https://ncats.nih.gov. engagement ≠ endorsement
- Website
-
https://ncats.nih.gov
External link for National Center for Advancing Translational Sciences (NCATS)
- Industry
- Research
- Company size
- 201-500 employees
- Headquarters
- Bethesda, Maryland
- Type
- Government Agency
- Founded
- 2011
Locations
-
Primary
Get directions
6701 Democracy Blvd
Bethesda, Maryland, US
Employees at National Center for Advancing Translational Sciences (NCATS)
-
Thomas C. Radman
Program Director at National Center for Advancing Translational Sciences
-
Rafat Sarosh
AI for Enterprise, Relentless Optimists and Practical Builder.
-
Zina Itkin
-
Audie Atienza
Senior Program Officer, NCATS/NIH [VIEWS ARE MY OWN]; Founder, The XA Project [501(c)(3) non-profit]
Updates
-
Thank you for the opportunity to celebrate and champion #WomenInScience! Check out this article on NCATS Director Joni Rutter ⬇
At a recent Mayo Clinic Celebration of Women in Science Lecture, Joni Rutter, Ph.D., director of the National Center for Advancing Translational Sciences (NCATS), highlighted the importance of inclusion to boost scientific progress. "Find your team" and "continuously expand your skillset" were Dr. Rutter's most consistent pieces of advice to help women advance their careers and research. Vesna Garovic, M.D., Ph.D., director of Mayo's Center for Clinical and Translational Science, says she felt inspired by how Dr. Rutter connected the inclusion of women in science to the principles of team science and translational science. "She challenged all of us to promote inclusion to create systemic change so that scientists can accomplish research more effectively, predictably and rapidly to meet the unmet needs of patients." Learn more: https://mayocl.in/3QVgedV #CTSAprogram #WomenInScience #DiversityInSTEM #NCATS
-
We’re speeding the drug approval process at NCATS! In the fight against #DuchenneMuscularDystrophy, researchers developed a new drug and performed clinical trials to test its effectiveness. These results led to an FDA approval! Learn more about our findings: https://go.nih.gov/tEX9tgW #RareDiseases
-
-
Register today! The second pre-application technical assistance webinar for the Rare Diseases Clinical Research Consortia notice of funding opportunity is Monday, June 3. Staff will provide an overview of the funding opportunity and answer questions from applicants. Join us at 3 p.m. EDT. https://go.nih.gov/9yxZo2B Rare Diseases Clinical Research Network (RDCRN)
-
-
NCATS staff and leadership had the exciting opportunity to discuss #N3C’s capabilities at the National Artificial Intelligence Research Resource (NAIRR) congressional demonstration earlier this week. The NAIRR pilot program aims to advance responsible discovery and innovation in #AI research. N3C is an available resource to support the NAIRR Secure pilot, a focus area of the NAIRR pilot program. NAIRR Secure will enable research that involves sensitive data and will assemble privacy and security-preserving resources. Learn about N3C: https://go.nih.gov/TKxCSKB 📸 NCATS Director Joni Rutter, Ph.D., pictured with NIH Associate Director for Data Science and Director of the NIH Office of Data Science Strategy Susan Gregurick, Ph.D.
-
-
New research sheds light on the early metabolic changes that occur in children with autism. Check out the study partially supported by NCATS’ #CTSAProgram ⬇️
As a mother of an adult autistic son, I read with interest this #NIH-funded study at UC San Diego which identified biochemical pathways that are responsible for most of the metabolic changes that occur between birth and the diagnosis of autism spectrum disorder (ASD) in a child. https://bit.ly/4dHrVib #autism #ASD #AutismResearch #research #NIH
Metabolism of Autism Reveals Developmental Origins
today.ucsd.edu
-
#TBT to last May when NCATS’ Clinical and Translational Science Awards (CTSA) Program partially funded research that expanded newborn screening to include hundreds of testable #RareDiseases. Find out more about the impact of this work: https://go.nih.gov/EqzzuZf #CTSAProgram
-
-
Annica Wayman, Ph.D., has been selected as the new NCATS deputy director. Dr. Wayman brings a highly tuned skill set as a researcher, science administrator, an educator and a champion for advancing #TranslationalScience. Please join us in welcoming Dr. Wayman to NCATS this June. 👏
-
-
SBIR Tip of the day: Make sure to clear all administrative requirements before submitting your SBIR and STTR grant apps. #DYK 5 errors account for 80% of the total errors in SBIR and STTR grant apps? Explore all requirements and more tips today: go.nih.gov/T73yInO #NCATS #NCATSsbir #smallbiz
Small Business Resources: Applicants | National Center for Advancing Translational Sciences
ncats.nih.gov
-
National Center for Advancing Translational Sciences (NCATS) reposted this
🌟 Excited to highlight the final panel of today's #ScientificWorkshop2024! A huge thank you to these leading regulatory experts for sharing their insights and driving forward the conversation on 'ultra-rare' disease therapies: Peter Marks, MD, PhD - Director, Center for Biologics Evaluation and Research, FDA, Joni L Rutter, PhD - Director, National Center for Advancing Translational Sciences (NCATS), The National Institutes of Health Janet Woodcock, MD - Former Principal Deputy Commissioner, FDA Annie Kennedy, The EveryLife Foundation's Chief of Policy, Advocacy, and Patient Engagement Tune in LIVE: https://bit.ly/3crHRGd #RareDisease #UltraRare #ScientificWorkshop2024 #FDA #NCATS #NIH
-